Licensor:
European biotech
Licensee:
Asian Pharmaceutical company
Product:
Small molecule recently launched in Western markets
Therap. Area:
Oncology
Situation:
Licensing rights for certain Asian territories had been recovered from previous global licensee. A new, reliable and diligent development partner for Asia had to be identified urgently.
Objectives:
Find the right partner for the respective Asian territories who makes the necessary investment in a timely manner and who appropriately values such license.
Activities:
After the suitable partner had been identified, a complex negotiation process could be driven to a very satisfactory result.
Results:
- Licensing, development and commercialization agreement signed. The new partner accepted appropriate performance clauses.
- Upfront and early milestone payments contributed significantly to the licensor’s balance sheet.
- The licensee is currently developing the compound in his territory with great success, generating outstanding clinical data.